£520.00

The 2023-2028 Outlook for Pseudomonas Aeruginosa Infection Treatments in the United States

Price data last checked 69 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 22 days • 22 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 31 January 2026 05 February 2026 10 February 2026 16 February 2026

Price Distribution

Price distribution over 22 days • 1 price levels

Days at Price
22 days 0 6 11 17 22 £520 Days at Price

Price Analysis

Most common price: £520 (22 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 22 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Pseudomonas Aeruginosa Infection Treatments in India
98% match

The 2023-2028 Outlook for Pseudomonas Aeruginosa Infection Treatments in India

£515.00 13 Feb 2026
The 2023-2028 Outlook for Gram-Positive Bacterial Infections in the United States
97% match

The 2023-2028 Outlook for Gram-Positive Bacterial Infections in the United States

£520.00 27 Jan 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States
97% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Antiseptics and Disinfectants in the United States
96% match

The 2023-2028 Outlook for Antiseptics and Disinfectants in the United States

£520.00 11 Feb 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Urinary Tract Infection Treatments in the United States
96% match

The 2023-2028 Outlook for Urinary Tract Infection Treatments in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Hospital Acquired Urinary Tract Infection Treatments in the United States
96% match

The 2023-2028 Outlook for Hospital Acquired Urinary Tract Infection Treatments in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Probiotic Ingredients in the United States
96% match

The 2023-2028 Outlook for Probiotic Ingredients in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for MRSA Drugs in the United States
96% match

The 2023-2028 Outlook for MRSA Drugs in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Topical Antiseptic Medications in the United States
96% match

The 2023-2028 Outlook for Topical Antiseptic Medications in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Disinfectant Aerosols in the United States
96% match

The 2023-2028 Outlook for Disinfectant Aerosols in the United States

£520.00 09 Feb 2026
The 2023-2028 Outlook for Air Treatment Products in the United States
96% match

The 2023-2028 Outlook for Air Treatment Products in the United States

£520.00 25 Jan 2026
The 2025-2030 World Outlook for Pseudomonas Aeruginosa Infection Treatments
96% match

The 2025-2030 World Outlook for Pseudomonas Aeruginosa Infection Treatments

Out of Stock 20 Feb 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Industrial Wastewater Treatments in the United States
96% match

The 2023-2028 Outlook for Industrial Wastewater Treatments in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Pressure Ulcer Treatments in the United States
96% match

The 2023-2028 Outlook for Pressure Ulcer Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Peripheral Neuropathy Treatments in the United States
96% match

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in the United States

£520.00 21 Apr 2026
The 2023-2028 Outlook for Lipopeptide MRSA Drugs in the United States
96% match

The 2023-2028 Outlook for Lipopeptide MRSA Drugs in the United States

£520.00 13 Feb 2026
The 2023-2028 Outlook for Viral Infections in the United States
96% match

The 2023-2028 Outlook for Viral Infections in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for Quinolones Urinary Tract Infection Treatments in the United States
96% match

The 2023-2028 Outlook for Quinolones Urinary Tract Infection Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Phycocyanin in the United States
96% match

The 2023-2028 Outlook for Phycocyanin in the United States

£520.00 19 Feb 2026
The 2023-2028 Outlook for Animal Probiotics in the United States
96% match

The 2023-2028 Outlook for Animal Probiotics in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States
96% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States

£520.00 07 Feb 2026